Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel chemotherary

DEDE, D.; GUMUSKAYA, B.; Guler, GÜLNUR; ONAT, DEMİRALİ; ALTUNDAG, K.; ÖZIŞIK, YASİN

Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel chemotherary

Copy For Citation

DEDE D. S., GUMUSKAYA B., Guler G., ONAT D., ALTUNDAG K., ÖZIŞIK Y. Y.

JOURNAL OF BUON, vol.18, no.2, pp.366-371, 2013 (SCI-Expanded)

Publication Type: Article / Article
Volume: 18 Issue: 2
Publication Date: 2013
Journal Name: JOURNAL OF BUON
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.366-371
Hacettepe University Affiliated: Yes

Abstract

Purpose: The aim of this study was to assess the changes in biologic markers of breast cancer ER, PR, HER 2 and Ki-67 in locally advanced breast cancer patients after neoadjuvant chemotherapy.